|4.80|| +0.11 / +2.35%|
Pacific Biosciences of California, Inc. develops, manufactures and markets sequencing systems to help scientists resolve genetically complex problems. The company has developed a technology to study the synthesis and regulation of DNA combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry, and optics. Its initial focus is on DNA sequencing market where a third generation sequencing platform using proprietary SMRT technology, the PacBio RS. The PacBio RS a third generation sequencing instrument that provides real-time information at the single molecule level which includes instrument platform that uses its proprietary consumables, including its SMRT Cells and reagent kits, providing a complete solution to the customer. The company was founded by Stephen Turner and Joseph V. Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
|Mike W. Hunkapiller||Executive Chairman, President & CEO|
|Susan K. Barnes||Executive VP, Chief Financial & Accounting Officer|
|Stephen W. Turner||Chief Technology Officer & Vice President|
|Jonas Korlach||Chief Scientific Officer|
|James Michael Phillips||Senior Vice President-Research & Development|